fredag den 26 april

Köpläge i amerikansk fondjätte

Pär Ståhl
Stockholmsbörsen
(), idag
-
-

Orphazyme
Orphazyme: Milestone reached in ALS (Redeye)

2019-07-18 12:19
Earlier today, Orphazyme announced that they have completed enrollment in the phase III program with arimoclomol in Amyotrophic Lateral Sclerosis (ALS). It means that it is on track to present top-line results in H1’21.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Orphazyme - I dag

{point.key}

Senaste nytt

Visa alla telegram

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex
Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor
Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor
Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror
Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -